[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Excess long term sickness", "description": "Self reported long covid\n\n2.2 million (3.4% of the population)\n\nOf those, as of 6 November 2022\n\n87% more than 12 weeks\n\n55% at least one year\n\n27% at least two years\n\nSymptoms \n\nFatigue 70%\n\nDifficulty concentrating 48%\n\nShortness of breath 46%\n\nMuscle ache 45%\n\nAdversely affected the day-to-day activities, 1.6 million (75% of self-reported long COVIDs)\n\nSelf-reported long COVID more common\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections\n\nAged 35 to 69 years\n\nFemales \n\nLiving in more deprived areas \n\nWorking in social care \n\nAnother activity-limiting condition or disability\u202f\n\nPeople not working and not looking for work \n\ni.e.\n\nIf you are working or actively looking for work you are less likely to report long covid\n\nProportions of LC\n\nVaccination status not given\n\nCumulative change in number of people aged 16 to 64 years inactive because of long-term sickness\n\nLong COVID is not the main factor\n\nWorking-age adults\n\n(Economically inactive because of long-term sickness)\n\nHas been rising since 2019\n\n363,000 more since start of pandemic\n\nONS reasons\n\nNHS waiting times\n\nLong-term sick\n\nother health problems or disabilities\n\n(may include LC)\n\nApril to June 2022\n\n97,000 higher than the same period in 2019\n\n(a 41% increase)\n\nExcess deaths, (ending 2 December 2022)\n\n372 deaths involving COVID-19 registered in the UK\n\n2.9% of all deaths\n\n(400 in the previous week)\n\nA total of 12,866 UK deaths\n\n5.1% above the five-year average\n\nZoe symptoms as of this week (13th December)\n\nSore throat, 64%\n\nRunny nose, 57%\n\nBlocked nose, 57%\n\nHeadache, 54%\n\nSneezing, 53%\n\nCough, no phlegm 53%\n\nCough with phlegm, 44%\n\nHoarse, 40%\n\nMuscle pains / aches 24%\n\nAltered smell, 20%\n\nSwollen neck glands, 19%\n\nDizzy, light headed, 19%\n\nFatigue, 17%\n\nLoss of smell, 17%\n\nSore eyes, 17%\n\nShortness of breath, 15%\n\nChest pain / tightness, 15%\n\nEarache, 15%\n\nChills or shivers, 13%\n\nWheezing, 11%\n\nFull Zoe report\n\nhttp://email.mg.joinzoe.com/c/eJwdjs1uwyAQhJ_G3IKWHxs4cOil70HYNSbC3gicVurT14k0h5Fm5tNQVIuDoGY_g8DoCcijqFGD1korA045HWTOblnX1ZBWzqClycJe5IPr8cckM-9iixnQAZpFeWcskrfg9WpCoNnONlglWtzO8zkm8zXp70uZj8Htmjd-oSzMpX1YVzRO7qnQ5e6dfwf1T_2n4u35ureab5jOJEWPD96OeuTUWx3tfavsqbY35R-jWUPB", "link": "https://www.youtube.com/watch?v=4k--CsyKTno", "date_published": "2022-12-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Vaccine dangers, UK Parliament debate", "description": "Mr. Andrew Bridgen MP expresses his views", "link": "https://www.youtube.com/watch?v=-MSKzoI72eU", "date_published": "2022-12-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Risks and benefits with Professor Fenton", "description": "Relative risk versus absolute risk with Professor Norman Fenton, Mathematician, Professor of Risk Information Management\n\nProfessor Fenton, YouTube channel\n\nhttp://youtube.com/@normanfenton81\n\nAnd Sub stack\n\nhttps://wherearethenumbers.substack.com/\nnormanfenton.com\n\nLink to video on Norman's channel\nhttps://www.youtube.com/watch?v=Va9aE98cFCA\n\nDownload the slides used in this video\nhttps://d7694293-ffb8-4ed0-a014-3581d49070e4.usrfiles.com/ugd/d76942_9aec73e0e123495dba17f070437aadc8.pdf\n \nNor\nWhat is risk information management?\n\nThinking about risk, what do we mean by absolute risk and relative risk\n\nSounds a bit like the level of risk can be presented in a way that gives a particular impression of a greater or a lessor risk or benefit?\n\nAre there occasions when a vested interest might want to give an impression of an increased benefit, or reduced risk from an intervention?\n\nHow could choosing RRR versus ARR influence the impression given for adverse reactions is medical journals?\n\nConversely\n\nAre there occasions when a vested interest might want to give an impression of a decreased risk from an intervention?\n\nSo will RRR always be higher than ARR?\n\nWhy can the RRR vary between populations and vary over time?\n\nSo using one of the two measures to estimate the risk/benefit ratio would lead to different conclusions?\n\nHow could risk / benefit reporting be optimised in the medical literature?\n\nDo you think the editors of prestigious international journals are aware of the differences between RRR and ARR?\n\nIn the case of this paper from the Journal of Expert Reviews of Vaccines\n\nEfficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115787/\n\nThe original phase three data gave an efficacy for Pfizer vaccine, at preventing infection with SARS-CoV-2 of 95%, but it turns out the ARR was 0.84%\n\nWhy are these figures so different?\n\nSo is it fair to say that the \u2018real world translation\u2019 of the ARR of the Pfizer vaccine over 5 to 6 months of use increased to 3.7%?\n\nWhat do we mean by number needed to treat?", "link": "https://www.youtube.com/watch?v=fgVpVHL8nkY", "date_published": "2022-12-12 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]